VIA

Virtus Investment Advisers Portfolio holdings

AUM $349M
1-Year Est. Return 25.41%
This Quarter Est. Return
1 Year Est. Return
+25.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$296M
AUM Growth
-$72M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
512
New
Increased
Reduced
Closed

Top Buys

1
+$2.01M
2
+$1.82M
3
+$1.75M
4
CSCO icon
Cisco
CSCO
+$1.7M
5
STT icon
State Street
STT
+$1.69M

Top Sells

1
+$32.2M
2
+$24.6M
3
+$19M
4
SMC
Summit Midstream
SMC
+$3.67M
5
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$2.09M

Sector Composition

1 Financials 33.24%
2 Healthcare 17.43%
3 Technology 12.41%
4 Industrials 9.1%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STOK icon
376
Stoke Therapeutics
STOK
$1.51B
$90.3K 0.03%
7,955
-5,368
ZYME icon
377
Zymeworks
ZYME
$1.4B
$90.1K 0.03%
7,178
-5,828
ATXS icon
378
Astria Therapeutics
ATXS
$718M
$90K 0.03%
16,792
+57
XENE icon
379
Xenon Pharmaceuticals
XENE
$3.15B
$89.7K 0.03%
2,867
-1,294
NRIX icon
380
Nurix Therapeutics
NRIX
$1.3B
$89.5K 0.03%
7,862
-124
GHRS icon
381
GH Research
GHRS
$868M
$89.3K 0.03%
+7,329
IMNM icon
382
Immunome
IMNM
$1.57B
$89.3K 0.03%
9,605
-2,956
MRUS icon
383
Merus
MRUS
$7.28B
$89.3K 0.03%
1,698
-2,269
UPB
384
Upstream Bio Inc
UPB
$1.33B
$89.3K 0.03%
+8,134
TERN icon
385
Terns Pharmaceuticals
TERN
$2.03B
$89.2K 0.03%
23,927
-986
ANAB icon
386
AnaptysBio
ANAB
$936M
$89.2K 0.03%
4,017
-6,909
PCVX icon
387
Vaxcyte
PCVX
$6.37B
$88.7K 0.03%
2,729
+857
CRVS icon
388
Corvus Pharmaceuticals
CRVS
$655M
$88.7K 0.03%
22,177
+1,862
IDYA icon
389
IDEAYA Biosciences
IDYA
$2.82B
$88.7K 0.03%
4,220
-2,148
REPL icon
390
Replimune Group
REPL
$705M
$88.4K 0.03%
9,513
-3,921
DNLI icon
391
Denali Therapeutics
DNLI
$2.56B
$88.1K 0.03%
6,300
-691
PRAX icon
392
Praxis Precision Medicines
PRAX
$4.66B
$87.8K 0.03%
2,088
-228
GPCR icon
393
Structure Therapeutics
GPCR
$2.23B
$87.8K 0.03%
4,232
-945
BLTE
394
Belite Bio
BLTE
$4.07B
$87.3K 0.03%
1,513
-1,076
VKTX icon
395
Viking Therapeutics
VKTX
$4.42B
$87.2K 0.03%
3,290
-140
TYRA icon
396
Tyra Biosciences
TYRA
$840M
$87.1K 0.03%
9,103
-1,715
KYMR icon
397
Kymera Therapeutics
KYMR
$4.67B
$86.8K 0.03%
1,988
-1,903
AVBP icon
398
ArriVent BioPharma
AVBP
$854M
$86.6K 0.03%
3,979
-2,369
GLUE icon
399
Monte Rosa Therapeutics
GLUE
$935M
$86.2K 0.03%
19,112
-1,961
MLYS icon
400
Mineralys Therapeutics
MLYS
$3.23B
$85.3K 0.03%
6,302
-7,192
14 15
16
17 18